BD to acquire Bard in $24 bln medical tech deal

St James Gold

23/04/2017 22:50

NEW YORK, April 23 (Reuters) - Becton Dickinson and Co 
 BDX.N  will acquire C R Bard Inc  BCR.N  in a $24 billion deal 
that will give shareholders of the target about 15 percent of 
the combined entity, the two medical technology companies said 
on Sunday. 
    The "definitive" cash and stock agreement, which has been 
approved by directors of both companies, values Bard shares at 
$317.00 each. 
     
 
 (Reporting by Jonathan Spicer and Ramavenkat Raman; Editing by 
Mary Milliken) 
 ((jonathan.spicer@thomsonreuters.com; +1 646 223 6253; Reuters 
Messaging: jonathan.spicer.thomsonreuters.com@reuters.net  
www.twitter.com/jonathanspicer)) 
 
Keywords: CR BARD M&A/BD